Zepbound vs Wegovy trial and compounded GLP-1s

Docs Who Lift - Een podcast door Docs Who Lift

Probeer Podimo de eerste 30! dagen gratis

Luister 30 dagen gratis naar exclusieve podcasts en duizenden luisterboeken

Drs. Karl and Spencer discuss the topline results from Surmount 5 which put Zepbound (tirzepatide) against Wegovy (semaglutide) for weight loss. They also discuss some news around compounded GLP-1s.

Visit the podcast's native language site